NCT07029165 Kidney Blood Flow During Exercise in Older African American Adults
| NCT ID | NCT07029165 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Boston |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2024-12-04 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2024-12-04 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this preliminary study is to learn if healthy older African American (AA) adults have a larger change in their kidney blood flow during exercise compared to White (W) adults. The main questions that this study aims to answer are: * Do healthy older AA adults have a larger decrease in kidney blood flow during exercise compared to W adults? * Do healthy older AA adults have a larger decrease in kidney blood flow during other types of stress compared to W adults? During one visit in the research lab, participants will: * Perform cycling exercise while lying down * Undergo a cold hand test * Perform a mental math test Completing this preliminary study will help researchers to understand more about why many AA adults have heart and kidney problems, so future research can study ways to reduce the number of AA adults who have these health issues.
Eligibility Criteria
Inclusion Criteria: * Self-report as either African American or White racial identity * Born in United States * Both biological parents identify as same racial identity as participant * Recreationally active (participating in physical activity for at least 20 minutes per day, at least three times per week, but not training for competitive events) * Fluent in English Exclusion Criteria: * Hispanic or Latino * Females who are pregnant or lactating * Cardiovascular or renal disease * Hypertension (blood pressure of more than or equal to 130/80 mmHg) * Diabetes * Obesity (body mass index of more than or equal to 30 kg/m2) * Smoker/Tobacco user * Acute medical conditions * Taking prescribed cardiovascular, antihypertensive, or renal medications
Contact & Investigator
Rachel C Drew, PhD
PRINCIPAL INVESTIGATOR
University of Massachusetts, Boston
Frequently Asked Questions
Who can join the NCT07029165 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, up to 79 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07029165 currently recruiting?
Yes, NCT07029165 is actively recruiting participants. Contact the research team at rachel.drew@umb.edu for enrollment information.
Where is the NCT07029165 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07029165 clinical trial?
NCT07029165 is sponsored by University of Massachusetts, Boston. The principal investigator is Rachel C Drew, PhD at University of Massachusetts, Boston. The trial plans to enroll 12 participants.